UK NHS Sponsored Charity "Our Future Health"
Our Future Health is a Private Limited Company by guarantee without share capital use of 'Limited' exemption, incorporated on 17 Sep 2019. It's director is Professor Sir John Bell, Regius Professor of Medicine at Oxford University. "Professor Bell sits on a wide range of advisory panels for public and private sector bodies responsible for biomedical research in Canada, Sweden, Denmark, France, Singapore and the UK. He sat on the Scientific Advisory Board for AstraZeneca from 1997 to 2000 and has sat on the Scientific Advisory Board of the Roche Palo Alto facility since 1998. He is a non-executive director of Roche AG (since 2001) and of Genentech (since 2009). He is a member of the Bill and Melinda Gates Foundation Scientific Advisory Committee."
The company is also a registered charity. It is funded by the UK government (UK research and innovation and Department for Science, Innovation and Technology, around £130M) and charitable and business partners:
- Alnylam
- Amgen
- AstraZeneca
- Biogen
- Boehringer Ingelheim
- GlaxoSmithKline (GSK)
- Illumina
- Janssen Research & Development, LLC facilitated by Johnson & Johnson Innovation
- MSD (Merck)
- Novartis
- Novo Nordisk
- Pfizer
- Randox Laboratories
- Regeneron Genetics Center
- Roche
- Thermo Fisher Scientific
They currently have a little over 1M participants:




Comments
Post a Comment